Improving the hemocompatibility of heart valves

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)


Heart valve replacement with a prosthetic heart valve (PHV) remains the most effective treatment for valvular diseases such as aortic stenosis (AS) and mitral regurgitation (MR); where degeneration is the most common aetiology followed by rheumatic disease. These relatively simple mechanical devices have considerably prolonged the lives of patients impacted with morbidity and poor prognosis. This has largely been possible to advancements in material science and valve design which have enhanced the durability of PHVs. However, issues with haemocompatibility such as haemolysis, thrombosis and calcification still often arise which can lead to mechanical obstruction or leaflet tearing, sometimes with fatal consequences. The journey to improving the haemocompatibility of heart valves has been complex, often driven by failure to join the loop between mechanical design and physiological requirements. This chapter explores two critical haemocompatibility themes; blood-valve surface interaction and the impact of valve design on blood flow, from early designs to refinement.
Original languageEnglish
Title of host publicationHemocompatibility of Biomaterials for Clinical Applications
Subtitle of host publicationBlood-Biomaterials Interactions
EditorsChristopher Siedlecki
Place of PublicationDuxford, UK
Number of pages35
Publication statusPublished - 3 Nov 2017


  • haemocompatibility
  • heart valve
  • pyrolytic carbon
  • prosthetic valve thrombosis
  • surface engineering
  • valve design


Dive into the research topics of 'Improving the hemocompatibility of heart valves'. Together they form a unique fingerprint.

Cite this